These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 53334)

  • 1. Editorial: Clinical concentrates of clotting-factor IX.
    Lancet; 1975 Nov; 2(7940):855-6. PubMed ID: 53334
    [No Abstract]   [Full Text] [Related]  

  • 2. [Advances in the field of hemophilia therapy].
    Loeliger EA; Veltkamp JJ
    Ned Tijdschr Geneeskd; 1968 Sep; 112(36):1593-5. PubMed ID: 5680135
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of hemophilia B with a new clotting-factor concentrate.
    Hoag MS; Johnson FF; Robinson JA; Aggeler PM
    N Engl J Med; 1969 Mar; 280(11):581-6. PubMed ID: 5764825
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of hemophiliacs with inhibitors].
    Fujimaki M
    Rinsho Ketsueki; 1985 Jul; 26(7):1059-68. PubMed ID: 3932719
    [No Abstract]   [Full Text] [Related]  

  • 5. [Non-activated and activated prothrombin complex concentrates, Proplex and Feiba, in the treatment of a hemophilia B patient with high titer inhibitor against factor IX].
    Niiya K; Hirose S; Taguchi H; Miyoshi I
    Rinsho Ketsueki; 1985 Jun; 26(6):980-4. PubMed ID: 3877825
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical use of factor IX concentrates].
    Nyman D
    Schweiz Med Wochenschr; 1975 Sep; 105(37):1188-90. PubMed ID: 1215901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and clinical use of P.P.S.B. (factors II, VII, X and IX concentrate).
    Soulier JP; Ménaché D; Steinbuch M; Blatrix C; Josso F
    Thromb Diath Haemorrh Suppl; 1968; 35():61-72. PubMed ID: 5761074
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of hemophilia.
    Rodeghiero F
    Ric Clin Lab; 1985; 15(4):289-303. PubMed ID: 3914697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor IX concentrates for clinical use.
    Thompson AR
    Semin Thromb Hemost; 1993; 19(1):25-36. PubMed ID: 8456321
    [No Abstract]   [Full Text] [Related]  

  • 10. A therapeutic concentrate of coagulation factors II, IX and X from citrated, factor VIII-depleted plasma.
    Middleton SM; Bennett IH; Smith JK
    Vox Sang; 1973 May; 24(5):441-56. PubMed ID: 4691239
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemophilia B with inhibitor].
    Takahashi I
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):502-5. PubMed ID: 9833555
    [No Abstract]   [Full Text] [Related]  

  • 12. [Concentrated antihemophilic globulin in the treatment of hemorrhagic syndromes].
    Baklaja F; Cvetković V; Stajić M; Krivokapić L
    Bilt Hematol Transfuz; 1976; 4(3):61-6. PubMed ID: 1008799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparinised clotting factor concentrates in patients with Christmas disease and liver disease.
    Preston FE; Malia RG; Lilleyman JS; Blackburn EK
    Thromb Haemost; 1977 Aug; 38(2):504-9. PubMed ID: 579492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion support for haemophiliacs.
    Allain JP
    Clin Haematol; 1984 Feb; 13(1):99-117. PubMed ID: 6426835
    [No Abstract]   [Full Text] [Related]  

  • 15. Heat treated New Zealand factor IX concentrate: comparison with Prothrombinex in patients with haemophilia B.
    Benny AG; Ockelford PA; Johns AS; Woodfield DG; Berry EW
    N Z Med J; 1986 Jun; 99(803):408-9. PubMed ID: 3461352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of F.IX-inhibitor bypassing activity contained in a commercial prothrombin complex concentrate (Proplex)].
    Sugimoto M; Fujimura Y; Okubo Y; Takahashi Y; Yoshioka A; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1984 Aug; 47(5):1181-9. PubMed ID: 6516702
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitor economics.
    Teitel J
    Semin Hematol; 2006 Apr; 43(2 Suppl 4):S14-7. PubMed ID: 16690371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeder With a Clot: Thrombosis Following Treatment of Bleeding in a Child With Severe Hemophilia B.
    Goh MC; Lam JCM; Tan AM; Bhattacharyya R
    J Pediatr Hematol Oncol; 2021 May; 43(4):e561-e563. PubMed ID: 32769563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant blood clotting proteins for hemophilia therapy.
    Limentani SA; Roth DA; Furie BC; Furie B
    Semin Thromb Hemost; 1993; 19(1):62-72. PubMed ID: 8456325
    [No Abstract]   [Full Text] [Related]  

  • 20. Joint WFH-ISTH session: issues in clinical trial design.
    Peyvandi F; Farrugia A; Iorio A; Key NS; Srivastava A
    Haemophilia; 2014 May; 20 Suppl 4():137-44. PubMed ID: 24762289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.